Dry Age-Related Macular Degeneration (AMD) Treatment With Rheopheresis Trial

Inclusion Criteria: * 50 to 85 years old * diagnosis of AMD in both eyes * must have dry AMD in the study eye * Study eyes with best-corrected ETDRS-visual acuity of 0.1-0.8 * peripheral veins allowing vascular access to establish the extracorporal circuit. Exclusion Criteria: * other retinal or choroidal disorders than AMD * optic nerve disease, glaucoma * conditions that limit the view of the fundus * acute bleeding in any eye General exclusion criteria for the treatment of Rheopheresis: * anaemia * haemorrhagic diathesis or coagulopathy * diabetes * serious acute or chronic kidney or liver failure * hypotension systolic \< 100 mmHg * chronic viral infection (HIV, hepatitis B, C) * epilepsia, psychosis or dementia * a malignant disease or any other condition with life expectancy \< 12 months * known history of alcohol or drug abuse and long term serious nicotine abuse